The Medical Letter on Drugs and Therapeutics
ADVANCE
RELEASE
ARTICLE
April 28, 2025
View Complete Issue         Table of Contents 2019 
Miudella – A Lower-Dose Copper IUD
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Miudella – A Lower-Dose Copper IUD
April 28, 2025 (Issue: 5106)
Miudella (Sebela), a copper intrauterine device (IUD), has been approved by the FDA for prevention of pregnancy for up to 3 years. Miudella is the second copper IUD to be approved in the US; ParaGard, which contains more copper and is approved...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Miudella – A Lower-Dose Copper IUD
Article code: 5106a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.